Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health
The collaboration donates and supports AI for making breast cancer screening more accessible and available in impoverished regions of the world
Therapixel receives FDA 510(k) clearance for MammoScreen™
AI-powered reading aid for screening mammography improves Radiologists’ performance in cancer detection
Therapixel presents the results of its Reader study at the Virtual ECR 2020
Do not miss our research presentation (RPS 702-7) at the "Artificial intelligence, radiomics and more" session
Therapixel to showcase its advanced AI for breast cancer screening at the Digital edition of ECR 2020
Visit our online booth to experience MammoScreen (Expo Hall X1, The Artificial Intelligence Exhibition)
Therapixel: DREAM Digital Mammography Challenge winner
Therapixel came in first place in the breast cancer screening AI competition having developed an algorithm that improved false-positive rate by 5%*
Therapixel Founder & CSO will speak at RSNA Annual Meeting
Discover our award-winning AI-based algorithm at RSNA on December 4th at 10:30 am, AI Showcase.